Copyright: ©Author(s) 2026.
Artif Intell Gastroenterol. Aug 8, 2026; 7(2): 120311
Published online Aug 8, 2026. doi: 10.35712/aig.120311
Published online Aug 8, 2026. doi: 10.35712/aig.120311
Table 7 Roadmap for clinical translation of artificial intelligence in advanced hepatocellular carcinoma
| Priority area | Required action | Goal |
| Validation | Multicenter, temporal, prospective evaluation | Transportability |
| Causal modeling | Incorporate counterfactual ML/uplift modeling | True treatment guidance |
| Reporting | Adherence to TRIPOD-AI/CONSORT-AI | Transparency |
| Calibration | Brier score, calibration plots | Reliable absolute risk |
| Clinical impact | Decision curve analysis, outcome trials | Demonstrate net benefit |
| Infrastructure | Federated learning, harmonization protocols | Data diversity and robustness |
- Citation: Meena BL, Behera B, Rudra OS, Sharma D. Artificial intelligence in prognostication and treatment response modeling in advanced hepatocellular carcinoma. Artif Intell Gastroenterol 2026; 7(2): 120311
- URL: https://www.wjgnet.com/2644-3236/full/v7/i2/120311.htm
- DOI: https://dx.doi.org/10.35712/aig.120311